Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
August 08, 2018 12:00 AM

Rockwell Medical settles with former CEO, CFO, 2 directors for $1.5 million

Jay Greene
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Rockwell Medical Technologies
    Former Rockwell Medical Technologies CEO Rob Chioini

    Rockwell Medical Inc., a Wixom, Mich.-based bioscience technology company, has hired a new CEO after reaching a settlement that includes $1.5 million in payments to two former top executives and two directors over disagreements on how to sell Triferic, the company's most promising drug.

    Rockwell said Wednesday that it has hired Stuart Paul as CEO, effective Sept. 4. Paul, a veteran drug industry executive, will also join the Rockwell board of directors.

    The settlement agreement is between five current directors of Rockwell and former CEO Robert Chioini, former CFO Thomas Klema, former director Patrick Bagley and director Ronald Boyd, who has agreed to resign from the board. Choini and Klema were fired in late May.

    "With these matters now firmly behind us, the board and management team will focus on executing on the company's near- and long-term objectives to realize the potential of our innovative renal drug therapies and drive value for our shareholders," Rockwell Chairman Benjamin Wolin said in a statement.

    Rockwell, which was founded in 1995 by Chioini, has been seeking approval for Medicare reimbursement for Triferic, a drug for kidney dialysis patients, for several years.

    The company (NASDAQ: RMTI) produces two FDA-approved main products, Triferic and Calcitriol. Triferic is used to replace iron and maintain hemoglobin in dialysis patients suffering from anemia. The generic drug Calcitriol, active vitamin D injection, is used to treat secondary hyperparathyroidism in patients undergoing dialysis.

    On Paul, Wolin said: "Having served in senior leadership roles with Baxter International, Gambro AB, Quest Diagnostics and Abbott Laboratories throughout his 25 year career, Stuart has substantial experience in the healthcare industry, including the renal space.

    "He is a well-rounded executive who not only brings significant operating expertise and commercialization know-how across both domestic and international markets, but he is also deeply familiar with the clinical development process. Stuart's successful track record of executing on commercialization strategies and driving growth and profitability will be critical to Rockwell Medical as we move forward."

    The terms of the settlement include:

    • Rockwell will make a total payment of $1.5 million, $750,000 of which was paid at settlement and the rest to be paid in nine installments of $83,000 each. The company will also pay Boyd an additional $30,000 when he signs per the settlement agreement.
    • Rockwell will accelerate vesting of stock options held by the four that were scheduled to vest through Oct. 2. They will have until May 24, 2020, unless the options expire sooner, to exercise any vested company stock options each of them hold.
    • Chioini and Klema agreed to forfeit a total of 313,600 unvested shares of Rockwell stock issued in March 2017 as a performance-based award.
    • Chioini and Boyd resigned from Rockwell's board.
    • For the next five years, the settling parties agreed not to try to participate in the management or operations of Rockwell or its affiliates or subsidiaries.
    • The parties agreed to drop a federal lawsuit without cost to either side.
    In addition to Wolin, the settling directors are Mark Ravich, John Cooper, Robin Smith and Lisa Colleran.

    In mid-June, Chioini and Klema filed a whistleblower lawsuit contending Rockwell's board members unduly enriched themselves with compensation and committed securities fraud. Rockwell denied the allegations and filed counterclaims against Chioini, Klema, Bagley and Boyd. Accounting and auditing firm Plante Moran PLLC quit Rockwell in June over failure of management to provide critical emails that affected a quarterly SEC filing.

    Over the past several years, Rockwell has financially underperformed, and activist shareholders have pressed Chioini to improve the company's governance, strategy and operations.

    Since May 22, Rockwell's share price has dropped from $5.94 to $5.12 on June 15 to $4.54 on Tuesday, when the settlement was announced. The stock's five-year high was $18.01 in July 2015.

    "Rockwell Medical settles with former CEO, CFO, 2 directors for $1.5 million" originally appeared in Crain's Detroit Business.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    congress prescription drugs
    PBMs, Big Pharma face off in House hearing
    Biden COVID copy_i_i.jpg
    Biden administration asks employers to help more workers who lose Medicaid
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing